Accele Biopharma, Inc.

Accele Biopharma (“Accele”) and Accele Venture Partners, a related special purpose venture fund, were formed to create a capital-efficient mechanism to identify, finance and manage groundbreaking early stage life science technologies that have the potential to dramatically improve human healthcare, have strong commercial promise and have the potential for generating early proof of concept data. To achieve this goal we have assembled an experienced management team, a group of sophisticated investors, a nationally recognized advisory board, excellent research facilities and the broad scientific expertise necessary to evaluate and manage such opportunities. Our approach is capital-efficient in that the management team will manage multiple early stage enterprises simultaneously. Once early preclinical and clinical milestones for a portfolio company are met, the Accele team will facilitate the subsequent financing and the hiring of a management team for a stand-alone company.